Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
出版年份 2019 全文链接
标题
Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)
作者
关键词
-
出版物
HYPERTENSION
Volume 75, Issue 1, Pages 51-58
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-12-02
DOI
10.1161/hypertensionaha.119.13569
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study
- (2019) Sadayoshi Ito et al. JOURNAL OF HUMAN HYPERTENSION
- Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria
- (2019) Sadayoshi Ito et al. Clinical Journal of the American Society of Nephrology
- Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study
- (2019) Hiroshi Itoh et al. HYPERTENSION RESEARCH
- Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension
- (2019) Hiromi Rakugi et al. HYPERTENSION RESEARCH
- Single- and multiple-dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects
- (2018) Manabu Kato et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Salt, Blood Pressure, and Aldosterone in Women and Men
- (2018) Friedrich C. Luft HYPERTENSION
- Biological Sex Modulates the Adrenal and Blood Pressure Responses to Angiotensin IINovelty and Significance
- (2018) Mohammad Zaki Shukri et al. HYPERTENSION
- Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
- (2018) Akira Nishiyama HYPERTENSION RESEARCH
- Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016
- (2016) Murray Epstein et al. AMERICAN JOURNAL OF MEDICINE
- The Effects of Aldosterone Antagonists in Patients With Resistant Hypertension: A Meta-Analysis of Randomized and Nonrandomized Studies
- (2015) Khagendra Dahal et al. AMERICAN JOURNAL OF HYPERTENSION
- Nonsteroidal antagonists of the mineralocorticoid receptor
- (2015) Peter Kolkhof et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
- (2015) Kiyoshi Arai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
- (2015) Bryan Williams et al. LANCET
- The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)
- (2014) HYPERTENSION RESEARCH
- Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: Systematic review and meta-analysis
- (2014) Francesco Pelliccia et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension
- (2012) H. Shibata et al. AMERICAN JOURNAL OF HYPERTENSION
- Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
- (2012) Stacie L. Daugherty et al. CIRCULATION
- Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease
- (2012) Hiroshi Yoshida et al. CURRENT PHARMACEUTICAL DESIGN
- Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension
- (2012) GianLuca Colussi et al. JOURNAL OF HYPERTENSION
- Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies
- (2010) A H Gradman et al. JOURNAL OF HUMAN HYPERTENSION
- Treatment of resistant hypertension
- (2010) Eduardo Pimenta et al. JOURNAL OF HYPERTENSION
- A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study
- (2009) Toshio Ogihara et al. HYPERTENSION RESEARCH
- Resistant Hypertension: Diagnosis, Evaluation, and Treatment
- (2008) David A. Calhoun et al. HYPERTENSION
- Blood Pressure Control in Patients With Comorbidities
- (2008) Roland E. Schmieder et al. Journal of Clinical Hypertension
- Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension
- (2008) David A. Calhoun et al. Journal of the American Society of Hypertension
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now